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The nefgenes of the human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) and the related simian
immunodeficiency viruses (SIVs) encode a protein (Nef) whose role in virus replication and cytopathicity
remains uncertain. As an attempt to elucidate the function of nef, we characterized the nucleotide and
corresponding protein sequences of naturally occurring nef genes obtained from several HIV-1-infected
individuals. A consensus Nef sequence was derived and used to identify several features that were highly
conserved among the Nef sequences. These features included a nearly invariant myristylation signal, regions of
sequence polymorphism and variable duplication, a region with an acidic charge, a (PXX)4 repeat sequence, and
a potential protein kinase C phosphorylation site. Clustering of premature stop codons at position 124 was
noted in 6 of the 54 Nef sequences. Further analysis revealed four stretches of residues that were highly
conserved not only among the patient-derived HIV-1 Nef sequences, but also among the Nef sequences of HIV-2
and the SIVs, suggesting that Nef proteins expressed by these retroviruses are functionally equivalent. The
"Nef-defining" sequences were used to evaluate the sequence alignments of known proteins reported to share
sequence similarity with Nef sequences and to conduct additional computer-based searches for similar protein
sequences. A gene encoding the consensus Nef sequence was also generated. This gene encodes a full-length Nef
protein that should be a valuable tool in further studies of Nef function.
Sequence variability is a well-documented feature of RNA
viruses in general and of the human immunodeficiency
viruses (HIVs) in particular. Sequence variability arises
from an error-prone viral polymerase, recombination during
virus replication, and selective pressures exerted by host
immunosurveillance. Sequence heterogeneity has been
noted among virus isolates obtained from the same individ-
ual (14, 19, 52), related contacts (4, 8), and different unre-
lated individuals (35, 47). The degree of sequence heteroge-
neity also varies among the different HIV genes (40, 47),
with env being the most diverse (26). Sequence diversity
among virus isolates may result in altered biological proper-
ties such as growth kinetics, virulence, cellular tropism, and
interactions with the immune response.
Most efforts to characterize the sequence variation of HIV
isolates have been directed toward the structural gene env
(4, 8, 26, 35, 42). Few studies have evaluated the sequence
variability of nonstructural, auxiliary genes such as nef.
Extensive sequence polymorphism has been demonstrated
among nefgenes obtained from several cultured isolates (47,
50). Because sequence changes occur during the propagation
of isolates in culture (43), the sequence variation present in
these cultured viruses may not accurately reflect the se-
quence heterogeneity present in vivo. Reports of sequence
diversity in uncultured HIV type 1 (HIV-1) nef genes have
been limited to the sequences of nef genes obtained from
sequential isolates of one infected individual (14) and to the
sequences of six nef genes derived from three infected
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individuals (27). An extensive analysis of Nef sequence
variation among isolates derived from a larger sampling of
unrelated individuals has not been described.
The nef gene is located near the extreme 3' end of the
HIV-1 genome and overlaps the 3' long terminal repeat
(LTR) (2). A similar gene is found in all primate lentiviruses
but is absent in other retroviruses. The Nef protein is
myristylated (2, 20, 24) and is localized predominantly to the
cytoplasm and cytoplasmic membranes of infected cells (20,
25), although nef expression has also been detected within
the nucleus (33). Deletion studies have shown that nef is
dispensable for virus replication in cultured cells (38, 60).
However, nef expression is essential in vivo for the mainte-
nance of high virus loads and disease progression in
macaques infected with the related simian immunodeficiency
virus (SIV) (32). SIV nef mutants appear competent to carry
out some replication in vivo, as shown by the induction of a
protective immune response within infected macaques (12).
Conservation of this gene among HIV-1, HIV-2, and the
SIVs and the predominance of nef-specific transcripts early
after infection (46, 51) further argue for a vital role for Nef in
the virus life cycle.
Three major approaches have been taken to explore the
function of nef. In the first approach, the growth rate of
viruses containing various nef mutations has been evaluated
in cultured cells (reviewed in references 11 and 28). Initial
reports suggested that nef acts as a negative regulator by
repressing LTR-mediated transcription and thus potentially
contributing to the maintenance of viral latency in vivo.
Although results from some studies have supported this
model, other studies have observed either no effect, a
positive effect, or differential effects of nef expression on
replication rates, depending on factors such as the isolate
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tested, the disease state of the donor, and the multiplicity of
infection (reviewed in reference 28).
A second approach has been to investigate the effects of
nef expression on host cell functions. Nef has been reported
to down-regulate the expression of three cellular proteins:
CD4 (21, 21a, 24, 61), interleukin-2 (39), and NF-KB (48).
These cellular proteins are intimately involved in the initia-
tion and maintenance of an effective immune response.
Therefore, Nef may allow infected cells to remain undetec-
ted by immunosurveillance, perhaps by blocking the activa-
tion of infected lymphocytes (21a). However, conflicting
reports (reviewed in reference 28) underscore the need to
evaluate further the effects of nef expression on these
cellular activities.
A third approach has involved the identification of known
cellular or viral proteins that share regions of amino acid
sequence similarity with Nef. This approach is based on the
observation that proteins sharing a certain functional prop-
erty also share residues that are critical for function. From
searches of protein sequence library data bases, regions of
sequence similarities with the following proteins have been
proposed: guanine-binding regulatory (G) proteins (24, 25),
ATP-specific protein kinases (54), Bel3 protein of the human
spumaretrovirus (41), class II human leukocyte antigens
(HLAs) (64), interleukin-2 receptor (54), thyrotropin recep-
tor (7), non-DNA-binding leucine zipper transcription fac-
tors (53), and scorpion peptides (65). Because these proteins
are quite diverse in their cellular activities, subcellular
localization, and amino acid sequences, it is doubtful that
Nef shares functional properties with all of these proteins.
The lack of a biochemical assay for Nef function in the
context of virus replication, however, precludes the direct
evaluation of the proposed sequence alignments for biolog-
ical significance.
The purpose of this study was to characterize the se-
quence variability of HIV-1 nef genes obtained directly from
infected individuals. We hypothesized that the encoded
amino acids critical to Nef function are highly conserved
among the nef genes of isolates obtained from unrelated
individuals. Alignment of the deduced Nef protein se-
quences allows these conserved amino acids to be identified.
Four stretches of highly conserved amino acids, or "Nef-
defining" sequences, have been identified that are present
within the Nef sequences of HIV-1, HIV-2, and the SIVs.
Using these Nef-defining sequences, we reevaluated the
reported protein sequence comparisons and conducted ad-
ditional computer-based searches for similar protein se-
quences. Also, a consensus amino acid Nef sequence was
deduced from the uncultured, patient-derived nefgenes. The
identification of this consensus sequence represents a logical
approach to delineate a functional Nef sequence. A gene
encoding the consensus Nef sequence was constructed, and
it encodes a full-length Nef protein as demonstrated by
immunoblot analysis.
MATERIALS AND METHODS
Study population. Heparinized peripheral blood was col-
lected from 12 male HIV-1-infected individuals who were
participants in the UNC AIDS Clinical Trials Group at the
University of North Carolina Hospitals (Chapel Hill, N.C.).
At the time of sample procurement, all study participants
had low CD4 counts (10 to 190 CD4+ cells per ml of blood),
displayed clinical symptoms of AIDS, and were undergoing
5'-azido-3'-deoxythymidine (AZT) therapy.
DNA preparation and nested-primer PCR amplification.
Peripheral blood mononuclear cells (PBMCs) were sepa-
rated by centrifugation through Lymphocyte Separation
Medium (Organon-Teknika-Cappel) and lysed in lysis buffer
(10 mM Tris [pH 7.5], 30 mM NaCl, 20 mM EDTA)
containing 0.5% sodium dodecyl sulfate (SDS) and 0.5 mg of
proteinase K per ml. Total cellular DNA was extracted with
phenol, ethanol precipitated, and resuspended in TE buffer
(10 mM Tris-HCl [pH 7.5], 0.1 mM EDTA).
Two sets of amplification primers were designed to anneal
to highly conserved segments' flanking the HIV-1 nef gene
(47). The OUTER primers (5' OUTER primer, 5' AAT-
AGA-GTT-AGG-CAG-GGA-TA 3'; 3' OUTER primer, 5'
CTG-GTC-TAA-CCA-GAG-AGA-CCC-AGT-AC 3') an-
nealed to positions 8338 to 8358 and 9533 to 9558, respec-
tively, of the HIV-1 HXB2 sequence (49). The INNER
primers (5' INNER primer, 5' CTC-GCA-GTC-[AG-AAG-
AAT-AAG-ACA-GGG-CTT-GGA-AAG-G 3'; 3' INNER
primer, 5' CGT-CCA-GAA-TTC-GGA-AAG-TCC-CCA-
GCG-GAA-AGT-C 3') annealed to positions 8754 to 8782
and 9436 to 9457 and included restriction sites for XbaI and
EcoRI, respectively (underlined).
Because HIV-1 proviral DNA is often present at low copy
numbers, we subjected total cellular DNAs to two rounds of
nested-primer polymerase chain reaction (PCR) amplifica-
tion (57) to obtain sufficient quantities for cloning. The first
amplification round was performed in 30 cycles with the
OUTER primers (1 p,M each), 0.5 ,g of DNA, 200 ,M each
of the four deoxyribonucleoside triphosphates, 10 mM Tris-
HCl (pH 7.5), 1.5 mM MgCl2, and 2.5 U of AmpliTaq
polymerase (Perkin-Elmer Cetus). Each cycle consisted of
denaturation for 1 min at 94°C, annealing for 1 min at 55°C,
and elongation for 1 min at 72°C, with the denaturation time
lengthened to 5 min during the first cycle and the elongation
time lengthened to 10 min during the last cycle. The PCR
product from the first amplification round (approximately
1,200 bp long) was diluted either 1:10 or 1:100 in fresh PCR
mixture containing the INNER primers and subjected to an
additional 30 cycles of amplification. PCR products from the
second amplification (approximately 730 bp long) were visu-
alized by ethidium bromide staining after agarose gel elec-
trophoresis. Control reactions included DNA from unin-
fected CEM cells (a gift from M. Cloyd) and CEM cells
persistently infected with the HIV-1 HXB2 isolate (49).
Cloning and sequencing. PCR products from the second
amplification were gel purified, and the DNAs were eluted,
cleaved with XbaI and EcoRI, and cloned by standard
techniques. Approximately 20% of the nef-containing clones
were selected for DNA sequence determination with Seque-
nase (United States Biochemical) by the dideoxy chain
termination method (55). To reduce heteroduplex formation
from reannealing during the PCR procedure, we used the
most dilute PCR product per sample that gave a detectable
band after the second amplification. To improve sampling,
PCR products were generated from two or more independent
amplifications prior to cloning.
Nucleotide misincorporation and recombination rates of Taq
polymerase. PCR-induced errors resulting from nucleotide
misincorporation and recombination are a significant con-
cern when sequencing PCR-derived products. To determine
the nucleotide misincorporation rate of Taq DNA poly-
merase in our amplification conditions, we mixed cloned
HIV-1 HXB2 DNA (approximately 100 nefgene copies) with
uninfected CEM DNA (0.5 ,ug) and subjected the DNAs to
nested-primer PCR amplification. Eleven of the amplified
HXB2 nef genes were then cloned and completely se-
quenced. Of the 6,831 bases sequenced, only 4 base changes
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from the known HXB2 sequence were detected, for a
misincorporation rate of 0.59 base change per 1,000 bases
sequenced, or 0.37 base change per nef gene amplified. This
misincorporation rate of approximately 10' nucleotides per
cycle is comparable to the previously reported Taq DNA
polymerase misincorporation rates (18, 23). All of the base
changes involved G-to-A transitions, and no hot spot for
nucleotide misincorporation was noted. For comparison, we
determined the frequency of nucleotide substitutions of the
seven nefgenes derived from Pt357 relative to the consensus
sequence derived for that patient. Of the 4,582 bases se-
quenced, we detected 154 base changes, or 33.6 base
changes per 1,000 bases sequenced.
Sequence error may also arise from PCR-induced hybrid
sequences generated by recombination, the switching of a
partially extended, denatured amplification primer from one
template molecule to another during annealing. To measure
the recombination rate under our PCR conditions, we mixed
HIV-1 NL432 DNA (1) (approximately 65 nef gene copies)
and HIV-1 HXB2 DNA (approximately 35 nef gene copies)
with 0.5 ,ug of uninfected CEM DNA. The nef genes were
then amplified by nested-primer PCR amplification. We
determined the DNA sequences of the 5'- and 3'-terminal
100 nucleotides of 95 amplified nef genes. Sixty sequences
corresponded to the NL432 DNA sequence, while the re-
maining 35 sequences corresponded to the HXB2 DNA
sequence. Recombination was detected in seven clones, or
7.4% of the amplified sequences. This recombination fre-
quency is similar to the recombination frequency of approx-
imately 5% previously described for tat (43). Since the
output DNA sequence ratio of 1.7 to 1 (NL432 to HXB2)
approximated the input DNA ratio of 2 to 1 (NL432 to
HXB2), the mix of nef sequences obtained after PCR ampli-
fication likely reflects the mix of sequences present in the
PBMC DNAs.
Sequence analyses and protein library data base searches.
Nucleotide and amino acid sequences were aligned by the
PileUp program of the University of Wisconsin Genetics
Computer Group sequence analysis software program
(GCG) (16). Additional sequence comparisons were con-
ducted by the BestFit, FastA, TFastA, Gap, and Word-
Search programs of GCG. To search for protein sequences
that share sequence similarity with Nef proteins, we
searched the PIR and SwissProtein library data bases with
query patterns based on the four Nef-defining sequences.
These searches were conducted by the GCG WordSearch,
TFastA, and FindPatterns programs and the Analysepl pro-
gram developed by Staden (59). Nef sequences were
searched for sequence and structural motifs by the Motifs
and ProfileScan programs of GCG, respectively.
Cells and retroviral vectors. HeLa cells and the am-
photrophic retroviral packaging cell line PA317 (44) were
grown in Dulbecco's modified Eagle's medium containing
glucose (4.5 g/liter), 2 mM L-glutamine, and 10% fetal calf
serum. From the aligned 54 Nef protein sequences, we
derived an HIV-1 consensus Nef sequence representing the
predominant amino acid at each position. DNA encoding
this consensus Nef sequence was generated by a combina-
tion of overlapping-primer PCR amplification (17) and site-
directed mutagenesis in which unique regions of four patient-
derived nef genes were coamplified into a full-length,
synthetic consensus nef gene (details to be described else-
where). After the sequence was confirmed, the consensus
nef gene was cloned into the Moloney murine leukemia
virus-based retroviral vector pLXSN (45) at the EcoRI site
in the forward (pLConsNefSN) and reverse (pLConsFenSN)
orientations. Plasmid DNA was purified by cesium chloride
gradient centrifugation. DNA concentration was determined
byA260. The molecule clone containing the HIV-1 consensus
nef gene will be deposited in the National Institutes of
Health AIDS Repository.
Generation of HeLa cells stably expressing the consensus Nef
protein. Retrovirus-mediated gene transfer was used to estab-
lish HeLa cells that stably express the consensus Nef protein.
PA317 cells (5 x 105 per 60-cm dish) were transiently trans-
fected with 10 ,ug of pLConsNefSN or pLConsFenSN by the
calcium phosphate method (45). Virus-containing superna-
tants were harvested 48 h later and stored at -70°C. HeLa
cells (106 per 100-cm dish) were either mock infected or
infected with 1 ml of the appropriate virus supernatant for 2
h at 37°C, washed once with phosphate-buffered saline
(PBS), and then incubated with fresh medium at 37°C.
Twenty-four hours after infection, cells were placed under
G418 selection (0.5 mg of active G418 per ml, Geneticin;
GIBCO-BRL). G418-resistant colonies were pooled and
maintained under G418 selection for approximately 2
months; then G418 selection was removed.
Immunoblot analysis. Pooled G418-resistant HeLa cells
were assayed for expression of the consensus Nef protein
following removal of G418 selection. Mock-infected HeLa
cells or HeLa cells infected with the pLConsNefSN or
pLConsFenSN retroviruses were washed with PBS,
trypsinized, and lysed in RIPA-PI buffer (0.02 M Tris base
[pH 8.0], 2 mM EDTA, 0.15 M NaCl, 1% Triton X-100, 1%
deoxycholate, 2 ,ug of aprotonin per ml, 1 p,g of pepstatin A
per ml, 100 p,g of phenylmethylsulfonyl fluoride per ml, 2 ,g
of leupeptin per ml). Cellular lysates were clarified by brief
centrifugation and electrophoresed through an SDS-13%
polyacrylamide gel. The resolved proteins were then trans-
ferred onto a nitrocellulose membrane, blocked with 3%
gelatin in TBST buffer (50 mM Tris-HCl [pH 6.8], 0.2 M
NaCl, 0.05% Tween 20), and incubated with rabbit anti-Nef
antiserum (a gift from L. Ratner, Washington University, St.
Louis, Mo.) overnight at 4°C. The blot was reacted with
alkaline phosphatase-conjugated goat anti-rabbit immuno-
globulin G (Cappel), and color was developed with the
substrates nitroblue tetrazolium (Promega) and 5-bromo-4-
chloro-3-indolylphosphate (Promega) in alkaline phos-
phatase buffer (100 mM Tris [pH 9.5], 100 mM NaCl, 5 mM
MgCl2).
Nucleotide sequence accession numbers. Nucleotide and
amino acid sequences have been submitted to GenBank and
have been assigned accession numbers L15476 to L15529.
RESULTS AND DISCUSSION
Characteristics of the patient population. The nucleotide
sequences from 54 unique nef genes were determined from
uncultured PBMC DNAs isolated from 12 unrelated infected
individuals. These 54 unique genes were obtained from a
total of 56 sequenced nef genes. Table 1 summarizes the
characteristics of the patient population and the number of
genes per patient represented in the analysis. All patients
had advanced HIV disease, as documented by low CD4
counts (<190 counts per ml of blood) and AIDS-defining
clinical symptoms.
Intraindividual and interindividual sequence variations.
Pairwise comparisons of nucleotide and predicted amino
acid sequences revealed extensive variation between the 54
nefgenes (Table 1). In general, the sequence variation noted
among nef genes obtained from the same individual (intrain-
dividual variation) was generally less than the sequence
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TABLE 1. Description of patient population for analysis of nef
sequence variation
Sample CD4 ~No. of genes Pairwise comparison(nl= sequenced (intraindividual % differenceb)(n = 12) (count/mi)' (n = 54) Nucleotidesc Amino acidsd
Pt357 140 7 1.2-11.2 2.3-18.5
Pt179 30 6 0.8-10.9 2.4-20.2
PtlO2 150 6 1.1-3.5 2.4-5.3
Pt164 10 6 0.6-2.3 1.0-3.4
Pt227 10 5 2.9-8.9 1.9-16.6
Pt248 40 5 1.0-8.9 1.5-14.6
Pt166 100 5 1.1-9.8 1.0-15.8
Pt192 20 4 2.2-4.0 2.3-5.1
Pt233 190 3 3.2-10.3 4.9-16.5
Ptl71 110 3 0.54.0 0.5-4.4
Pt226 80 2 NpDe ND
Pt175 20 2 ND ND
a The CD4 count per milliliter of blood at the time of sample collection.
b Percent difference was calculated as the number of sequence substitutions
per number of possible positions x 100.
Interindividual, 0.3 to 13.2%.
d Interindividual, 0.5 to 22.7%.e ND, not determined because of small sample size.
variation found among nefgenes obtained between different
individuals (interindividual variation). At the nucleotide
level, the intraindividual variation ranged from 0.6 to 2.3%
(Ptl64) to 1.2 to 11.2% (Pt357), and the interindividual
variation was 0.3 to 13.2%. At the amino acid level, the
intraindividual variation ranged from 0.5 to 20.2%, while the
interindividual variation was 0.5 to 22.7%.
Pattern of amino acid conservation among the Nef se-
quences. The 54 predicted Nef amino acid sequences were
optimally aligned, and a consensus Nef sequence was de-
rived (Fig. 1). Only the nucleotide sequences that predicted
unique Nef protein sequences are presented in this study.
Taq-induced sequencing errors contributed minimally to
the sequence heterogeneity noted among the nef genes, as
shown by control experiments measuring the nucleotide
misincorporation and recombination rates generated by Taq
under our PCR amplification conditions. Also, our experi-
mental design avoided selection for particular nef sequences
during culturing. Overall, the extent of sequence variation
present within the nef genes is predominantly due to the
naturally occurring diversity.
The pattern of sequence variation was not distributed
equally throughout the length of the Nef protein. Rather,
some regions included amino acids that were invariant or
highly conserved among all Nef sequences (e.g., positions 72
to 78, numbered according to the consensus Nef sequence),
while other regions (e.g., positions 8 to 15) included poorly
conserved amino acids and in-frame deletions and/or inser-
tions. These clusters of poorly conserved regions tended to
be near the amino and carboxyl termini, as has been previ-
ously suggested (14, 27), but some variable positions also
appeared internally.
Features of HIV-1 Nef sequences. Conserved features
present at the N terminus of the Nef sequences included an
intact initiator methionine (ATG codon) and a highly con-
served myristylation signal (residues 2 to 7). Conservation of
the myristylation signal was expected since the subcellular
targeting of Nef proteins to cytoplasmic membranes depends
on the presence of an intact myristylation signal (66). The
amino acid sequence encoding the myristylation signal was
nearly invariant among our HIV-1 Nef protein sequences,
although considerable sequence variation has been de-
scribed in the myristylation signals of Nef sequences ob-
tained from cultured HIV-1, HIV-2, and SIV isolates (47).
Except for the required glycine at position 2, much sequence
diversity is allowed among functional myristylation signals
encoded by a variety of membrane-bound proteins, including
other myristylated retroviral proteins such as Gag (30).
Therefore, the highly conserved sequence of the Nef my-
ristylation signal suggests that this stretch of amino acids
may serve a critical, yet undetermined function other than
just myristylation.
The myristylation signal was followed by a stretch of
seven or eight amino acids that exhibits extensive sequence
polymorphism compared with other regions of the Nef
sequence. Numerous nonconservative and conservative
amino acid substitutions were present within this region,
with the exception of a highly conserved glycine or glutamic
acid at position 12 and a highly conserved tryptophan at
position 13. Sequence polymorphism in this region appeared
to be a shared feature of Nef protein sequences, since highly
variable sequences were present in the nef sequences from
all DNA samples tested. The pattern of amino acid variation
at this site suggests a lack of selection, rather than a
tolerance of specific amino acid substitutions. Therefore,
this region may serve as a flexible spacer region and is
predicted to lie on the external surface of the folded protein.
The methionine at position 20 has been shown to serve as
a site for internal initiation, resulting in a nonmyristylated
and truncated 25-kDa Nef protein rather than the full-length,
myristylated 27-kDa Nef protein (29, 36, 67). The methionine
at this position was highly conserved among our HIV-1 Nef
protein sequences. In contrast, none of the reported SIV Nef
sequences contained a methionine at this position (47),
indicating either that internal initiation may not be a signif-
icant feature for generating a functional Nef protein or that
other primate lentiviruses have no need for an internally
initiated Nef protein.
A variably duplicated region (between positions 22 and 23)
was present in 28 of the 54 Nef protein sequences derived
from 8 of the 12 patients (Fig. 1). This region represented an
imperfect duplication of the adjacent downstream sequence
(positions 23 to 29). The duplications varied in length from 3
to 10 amino acids (data not shown). On an individual basis,
the frequency of the duplication ranged from all of the genes
sequenced (Pt192, Pt175, and Pt166) to one-third of the genes
sequenced (Pt179 and Pt227). No duplication was noted in
the sequences derived from Pt164, Pt248, Ptl71, or Pt226.
Similar duplications have been reported for the nef gene of
the brain-derived HIV-1 isolates BRVA and JR-CSF (47) and
from isolates obtained from circulating lymphocytes and
pathologic brain tissues of infected adults and children (6).
Such variable regions frequently represent loops within a
folded protein structure. Because of their diversity, the
amino acid sequences present at positions 7 through 23 may
be a useful marker for virus typing in transmission studies.
The Nef sequences also contained the highly conserved
sequence R-P-M-T-Y-K (positions 77 to 82), which is a
potential recognition site for phosphorylation by protein
kinase C (PKC). The PKC recognition pattern (31) can be
summarized as follows: (R/K, XO2)-S/T-(XO-2 R/K), where
the phosphoacceptor group (serine or threonine) is preceded
and/or followed by a basic residue (arginine or lysine)
positioned one, two, or three residues from the phosphoac-
ceptor group (X = any amino acid). Although PKC can
phosphorylate substrates containing only C-terminal or
N-terminal basic residues, PKC avidly phosphorylates sub-
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FIG. 1. Amino acid sequence variation within 54 uncultured HIV-1 nefgenes. HIV-1 Nef protein sequences were deduced from 54 unique
HIV-1 nef genes obtained from 12 infected individuals following nested-primer PCR amplification of uncultured PBMC DNAs. The top line
depicts the consensus Nef sequence with the predominant residue at each position. The amino acid variation is represented below each
position. Subscripted numbers reflect the number of times that amino acid was found at that position. Position numbering is for the consensus
Nef sequence. Gaps (.) were introduced to maximize the alignment. Residues following premature termination codons (*) were not included
in this summary. The locations of the myristylation signal, sequence polymorphism, variable duplication, highly charged/acidic region (acidic,
charged), (PXX)4 repeat sequence, putative PKC phosphorylation site (PKC), PPT, 5' border of the 3' LTR (I - - ->), IR, and predicted
beta-turn are shown above the consensus Nef sequence (see text for details).
strates that possess basic residues at both positions (31). All
the HIV-1 Nef sequences, as well as the Nef sequences from
HIV-2 and the SIVs, contained a putative PKC recognition
site which included both C-terminal and N-terminal basic
residues (Fig. 1 and 2). Therefore, PKC-mediated phos-
phorylation at this site is a potential biochemical modifica-
tion of Nef proteins. Although the threonine at position 15
has been reported to be a target of PKC-catalyzed phosphor-
ylation (24, 25), this particular potential phosphorylation site
(T/S) was present in only 20 of the HIV-1 Nef sequences and
was poorly conserved among the Nef protein sequences of
HIV-2 and SIV (Fig. 2). Another poorly conserved potential
PKC recognition site (S-X-K/R) was found at positions 103
to 105 in 37 of the HIV-1 Nef sequences. Other weakly
conserved potential phosphorylation sites (31) encoded by
the HIV-1 nef sequences included a casein kinase II recog-
nition site [(S/T)-X-X-(D/E)] at positions 15 to 18 (20 Nef
sequences) and 157 to 160 (24 Nef sequences) and a tyrosine
kinase recognition site [(R/K)-X-X-X-(D/E)-X-X-X-Y] at po-
sitions 94 to 102 (36 Nef sequences).
Three other sequence features can be recognized among
the Nef sequences. First, a highly conserved acidic region
composed mainly of glutamic acid residues was located at
positions 62 to 65. Because of its highly charged nature, this
stretch of amino acids may lie on the external surface of the
folded protein. Second, a sequence containing a highly
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HIVlcons E-EVL-WkFD SRLAf--mAr E-HPEYyKd-
1:1 1:11 : 11:
HIV2cons HGETLVW-FD P-LAy-Y-AF I--PEEFGHK SGLPE-EWKA kLKARGIPfS
SIVagml55 HGEILAWKFD PMLAVQY... DPSREYFTDL YSTVGTGN
SIVagm3 HGEVLVWKFD PMLAVQY... DPNRKYLTDM HDLGKRK
SIVagmtyo HGEILVWKFD PMLAIQY... DPNREYFTDM HGLVKRK
SIVagm677 HGEVLVWKFD PKLAVEY... RPDM..FKDM HEHAKR
SIVmm239 WGEVLAWKFD PTLAYTYEAY VRYPEEFGSK SGLSEEEVRR RLTARGLLNM ADKKETR
SIVmne WGEVLVWKFD PTLAYTYEAY IRYPEEFGSK SGLSEEEVRR RLTARGLLKM ADKRETS
SIVmml42 WGEVLAWKFD PTLAYTYEAY IRYPEEFGSK SGLSEKEVKR RLAARGLLEM ADRKETS
SIVcpz DKEVLVWRFD SRLALRHIAR EQHPEYYKD
SIVmndgbl EGETLMWSGT LILPMTLQH
FIG. 2. Sequence similarity between invariant and highly conserved residues of the patient-derived HIV-1 consensus Nef sequence and
the Nef protein sequences from HIV-2 and SIV. The consensus Nef sequence (HIV-lcons) was aligned with the HIV-2 consensus Nef protein
sequence (HIV2cons; derived from HIV-2 strains ROD, GH1, D194, BEN, ISY, and ST [47]) and the Nef protein sequences from 9 SIV
strains (47), using the PileUp program of GCG (16). Because of the extensive sequence heterogeneity noted among SIV Nef sequences, these
sequences were not summarized into a consensus sequence. Gaps (.) were introduced to maximize the regions of alignment. HIV-lcons and
HIV2cons depict the sequence variations within the 54 deduced HIV-1 Nef protein sequences and the 6 HIV-2 Nef sequences. The sequence
variation at each amino acid position within HIV-lcons and HIV2cons is defined as being one of the following: 95 to 100% of the residues
are identical (upper case); 95 to 100% of the residues have only conservative substitutions (lower case); less conserved (-). The amino acid
sequence similarity of the HIV2cons and the SIV Nef sequences with HIV-lcons is defined as one of the following: 90 to 100% of the residues
are identical to the corresponding HIV-lcons residue ( ); 80 to 100% of the residues represent conservative substitutions of the
corresponding HIV-lcons residue (:). Blocks A, B, C, and D indicate stretches of amino acids that are highly conserved among the Nef
proteins of HIV-1, HIV-2, and the SIVs. The locations of the PPT and the 5' border of the 3' LTR ( -*) are indicated above the alignment.
Position numbering is for the HIV-1 consensus Nef sequence. Conservative amino acids are grouped as follows: A, S, T, G, and P; V, .L, I,
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conserved proline followed by two residues was repeated
four times in succession [(Pxx)4] within positions 69 to 80.
This repeat was also highly conserved among the Nef protein
sequences obtained from cultured HIV-2 and SIV isolates
(47), although there the Pxx sequence is repeated three times
rather than four times (Fig. 2). This (Pxx)4 repeat sequence
can be found in numerous proteins with diverse biological
properties, including the proline-rich domain of the murine
leukemia virus envelope protein (56). Although the signifi-
cance of this repeat sequence within the Nef protein se-
quence is unknown, it probably represents a structural
element. Third, the highly conserved G-P-G-I/V sequence
located at positions 130 to 133 is highly predictive of a
beta-turn (10). The third variable domain (V3) of HIV-1 env
encodes the similar sequence G-P-G-R which forms the tip of
the V3 loop structure (35).
Conservation of cis-acting RNA and DNA elements. During
virus replication, the U3 and U5 regions located at the ends
of the retroviral RNA genome are duplicated during reverse
transcription to form the LTRs (reviewed in reference 62).
The polypurine tract (PPT) is one essential element for
reverse transcription that is located within the nef coding
sequence. The PPT serves as the primer for initiation of
second-strand DNA synthesis. The PPT consists of a purine-
rich region of 16 nucleotides that lies immediately upstream
of the 5' border of the 3' LTR. Among our nefgenes, amino
acid sequences encoded in the PPT were highly conserved
(codon positions 91 to 96; i.e., glutamic acid, lysine, and
glycine residues) and reflected the purine-rich composition
of this sequence. The nucleotide sequences maintained the
AIG-rich composition while encoding different amino acids,
exemplified by the amino acid variation noted at position 94.
Therefore, sequence conservation in this region is probably
due to constraints at the level of the RNA sequence for virus
replication, rather than at the protein level.
The inverted repeat (IR) is a critical element of the LTR
that is located within the nef gene. In retroviruses, the IR is
a short, inverted repeat located at the 3' end of U5 and the 5'
end of U3. IR sequences are critical for proper cleavage and
integration of the proviral DNA into the host chromosome
(reviewed in reference 62). Among our nef genes, the nucle-
otide sequences encoding the IR were relatively conserved
(data not shown) and reflected the sequence variation previ-
ously described for cultured HIV-1 isolates (47).
Studies of HIV LTR gene expression in vitro have iden-
tified at least five potential binding sites for cellular tran-
scription factors in the U3 region overlapping the 3' end of
the nef gene (reviewed in reference 22). These regions
include sites for chicken ovalbumin upstream promoter
transcription factor (COUP-TF), activator protein (AP-1),
nuclear factor 1 of activated T cells (NFAT-1), upstream
stimulatory factor (USF), and T-cell factor 1 alpha (TCF-
lot). We aligned five regions within the deduced HIV-1 Nef
sequences that overlap these putative sites. The locations of
these sites within the consensus Nef codon sequence are as
follows: COUP-TF, positions 125 to 140; AP-1, positions 133
to 135 and 138 to 139; NFAT-1, positions 151 to 163 and 176
to 180; USF, positions 190 to 195; and TCF-la, positions 202
to 206. The nucleotide sequences that encode these binding
sites were fairly conserved within the nef sequences but, in
general, do not overlap the Nef-defining sequences (data not
shown). The exceptions are the COUP-TF and AP-1 sites
which partially overlap block C.
Premature stop codons at position 124. An unexpected
finding was the clustering of premature stop codons at
position 124 (normally encoding tryptophan) in six se-
quences derived from 4 of the 12 individuals. Analysis of the
sequence similarity of these six sequences with the other
sequences from these individuals revealed that the stop-
encoding sequences were not a result of contamination with
HXB2, an HIV-1 clone used in our laboratory that also
encodes a premature stop at this position (data not shown).
The clustering of premature stops appeared to be specific for
position 124, given the lack of premature stop codons at
nearby tryptophan-encoding codons (positions 113 and 141).
Furthermore, the HIV-1 BH10 clone (49) and two nefclones
isolated from uncultured PBMCs of two unrelated, HIV-1-
infected individuals (27) also encode premature stops at
position 124. The premature stops do not appear to be the
result of G-to-A hypermutations, concentrated regions of
extensive G-to-A transitions that typically involve GpA
dinucleotides (63), because only one of the prematurely
truncated nefsequences (Pt357) contained a region of poten-
tial G-to-A hypermutation. In this case, there were only five
G-to-A transitions within a 100-nucleotide stretch, and only
one of the transitions involved a GpA dinucleotide (data not
shown). No region of G-to-A hypermutation was noted in the
remaining sequences encoding either a prematurely trun-
cated or full-length Nef protein. Although most published
nef sequences are open, other investigators have reported
the presence of premature stop codons within the coding
sequences of tat (43), rev (40),pol (58), and env (4, 42) genes,
as well as among nefgenes isolated from PBMCs (14, 49) and
other tissues (6). Clustering at position 124 suggests that
truncated Nef proteins may be generated in vivo and may
display altered properties compared with the full-length Nef
protein.
Identification of four Nef-defining sequences. One of the
goals of this study was to identify stretches of amino acids
that were highly conserved not only among the Nef se-
quences derived from uncultured HIV-1 isolates, but also
among HIV-2 and SIV isolates. The rationale for this goal is
that, regardless of their source, all functional Nef proteins
must contain certain amino acids that are critical for activity.
To identify these highly conserved regions, we aligned the
HIV-1 consensus sequence with a consensus sequence de-
rived from six HIV-2 Nef protein sequences (HIV-2 isolates
ROD, GH1, D194, BEN, ISY, and ST [47]) and the Nef
protein sequences from 9 SIV isolates (AGM155, AGM3,
AGMTYO, AGM677, MM239, MNE, MM142, CPZ, and
MNDGLB1 [47]). We chose not to derive a consensus
sequence for the SIV Nef sequences since they are the most
diverse in amino acid composition and length, and some SIV
isolates were derived from different hosts. From this align-
ment (shown in Fig. 2), four stretches of highly conserved or
invariant amino acids were identified and are referred to as
blocks A through D. Block A (positions 64 to 90) denotes a
stretch of 27 amino acids that includes the acidic/charged
region, the (Pxx)4 repeat, and the potential PKC phos-
phorylation site. Block A was not extended to include the
highly conserved amino acids overlapping the PPT, since
sequence conservation here is probably due to constraints
for virus replication (see above). The other blocks include
block B at positions 106 to 114, block C at positions 130 to
148 (including sequences that may form a predicted beta-turn
structure), and block D at positions 179 to 190. These blocks
include most of the highly conserved stretches of amino
acids. Exceptions are short stretches that include the con-
served D-W-Q/N sequence (positions 123 to 125) located
between blocks C and D, and the conserved L-L-H-P
sequence (positions 164 to 167).
Although the nucleotide sequences encoding blocks B, C,
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FIG. 3. Location of published protein sequence alignments in
relation to the Nef amino acid variation pattern. The top portion of
the graph depicts the percentage of nonconservative amino acid
substitutions at each position that were derived from alignment of
the 54 patient-derived Nef sequences. The percentage of noncon-
servative amino acids found at each position is indicated on the y
axis; the amino acid position corresponding to the consensus Nef
sequence is depicted on thex axis. The bottom portion of the graph
shows the location along the consensus Nef sequence of the
published alignments of protein sequences reported to share limited
sequence similarity with various Nef proteins (7, 25, 41, 53, 54, 64,
and 65). 1, G proteins: la = P site, lb = C site, ic = G site; 2,
leucine zipper motif; 3, Bel3 of human spumaretrovirus; 4, HLA
class II antigens; 5, interleukin-2 receptor; 6, thyrotropin receptor;
7, scorpion peptides; 8, ATP-binding site of the protein kinase
family. ----, indicates variable spacing used to maximize the
sequence alignments, as reported in the initial published alignments.
and D were also present within the U3 region, these three
blocks did not significantly overlap any known cis-acting
DNA element, with the exception of the AP-1 and COUP-TE
binding sites which partially overlap block C. Residues that
were highly conserved among the HIV-1 Nef protein se-
quences corresponded to highly conserved residues of Nef
sequences from HIV-2 and the SIVs, making it likely that the
Nef proteins from these viruses are functionally equivalent.
Reevaluation of reported sequence similarities. Several
investigators have proposed sequence similarities between
Nef proteins and known cellular or viral proteins based on
alignments with Nef sequences deduced from cultured
HIV-1, HIV-2, and SIV isolates (47). Proposed protein
similarities include G proteins (24, 25), ATP-specific protein
kinases (54), Bel3 protein of human spumaretrovirus (41),
class II HLAs (64), interleukin-2 receptor (54), scorpion
peptides (65), thyrotropin receptor (7), and non-DNA-bind-
ing leucine zipper transcription factors (53). The location of
these alignments along the length of the Nef sequence is
shown in Fig. 3. Because of the diverse activities displayed
by these proteins, it is unlikely that Nef exhibits functional
characteristics of all of these proteins. It is difficult to
determine which, if any, of these diverse proteins share
activity with Nef proteins. Therefore, we reassessed these
reports by aligning the reported protein sequences to our
HIV-1 Nef sequence data (Fig. 3) and to the four Nef-
defining sequences (Fig. 4), using the alignments published
in the original reports. We reasoned that the proposed
regions of sequence similarity should include the Nef-defin-
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FIG. 4. Sequence similarity between Nef-defining sequences and
protein sequences previou§ly reported to share partial sequence
similarity with Nef proteins. The amino acid sequences of cellular or
viral proteins proposed to share sequence similarity with Nef
proteins were aligned with the Nef-defining sequences, depicted as
blocks A through D. These blocks represent stretches of amino
acids that are highly conserved among Nef protein sequences
derived from our uncultured HIV-1 isolates and from cultured
HIV-2 and SIV isolates (Fig. 2). We derived consensus sequences
that summarize the amino acid sequence variation present within the
blocks as follows: 90% of the residues are identical (upper case);
90% of the residues represent only conservative substitutions (lower
case); less conserved (-). Sequence comparisons between blocks A
through D and the reported protein sequences are indicated as
follows: residues are identical ( ), or residues are conservative
substitutions (:). Only the protein sequences that were shown in the
initial published alignments and overlap the Nef-defining sequences
are shown. Numbering is of the HIV-1 consensus Nef sequence.
Amino acid coordinates are presented at the beginning of the
sequences (see references 7, 25, 41, 53, 54, 64, and 65). Amino acid
coordinates are not shown for the leucine zipper and G protein (C
site) since canonical sequences are given. Gaps (.) were introduced
to maximize the regions of alignment.
Alignment of the proposed protein sequences with blocks
A through D (Fig. 4) revealed that portions of the eight
protein sequences overlapped the Nef-defining sequences.
Upon closer inspection, however, the overall extent of
amino acid sequence similarity was relatively small, as
demonstrated by the lack of significant sequence identify or
conservation between most of the sequences.
The alignment that shared the greatest number of invariant
and highly conserved amino acids was between the HLA
class II antigens (DQ, DR, and DP) and block A (Fig. 4). The
two sequences shared four positions of identical amino acids
and four positions of highly conservative amino acids. The
J. VIROL.
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region of limited sequence similarity overlapped the CD4
binding region within the immunoglobulinlike second extra-
cellular domain of the HLA class II beta-chain (9, 34). It has
been speculated that the autoimmunelike response fre-
quently observed in patients with AIDS may be induced
against the HILA class II beta-chain by the Nef protein
through molecular mimicry (64). However, nef expressed
from viral vectors (21, 21a, 24, 25) has been shown to
suppress cell surface CD4 expression in human cell lines of
diverse origins through an interaction that appears to involve
the cytoplasmic domain of CD4 (21). These data suggest that
the Nef protein and the HLA class II antigens may share a
common biological property, although the sequence compar-
isons weakly support this hypothesis.
The ATP-binding site of protein kinases such as cyclic
AMP-dependent protein kinases showed partial sequence
similarity to block B. The sequence D/K-I-L-D/N, a highly
conserved sequence that is found within the nucleotide
binding domain of protein kinases (5), was also relatively
conserved among Nef sequences (positions 108 to 111, Fig.
4). Sequences corresponding to other sites which are critical
in binding and hydrolyzing ATP were not present within the
Nef-defining sequences, however. These critical sequences
included the glycine-rich canonical G-X-G-X-X-G sequence
and a lysine positioned 15 to 28 amino acids C terminal to the
glycine-rich sequence (5). Moreover, biochemical assays
have failed to demonstrate ATP-binding and hydrolysis
activities in purified Nef proteins (reviewed in reference 28),
making it unlikely that Nef functions as an ATP-dependent
protein kinase.
The remaining alignments demonstrated weak sequence
relatedness between the Nef-defining sequences and re-
ported cellular or viral proteins (Fig. 4). As an example, Guy
et al. (24, 25) have reported that five Nef protein sequences
(isolates HIV-1 BRU, HIV-1 ARV2, HIV-2 ROD, SIV
MAC251, and SIV AGM [47]) share regions of sequence
relatedness with three GTP-binding elements of G proteins,
signal-transducing proteins having properties of GTP hydro-
lysis, GTP binding, and autophosphorylation (e.g., p2l').
These highly conserved elements are the P site (canonical
G-X-X-X-X-G-K sequence, also referred to as the A site),
the C site (D-K-X-G), and the G site (N-K-X-D) (15, 37).
Although weak GTP-binding and GTPase activities were
exhibited by bacterially expressed and partially purified Nef
proteins (24, 25), subsequent studies by other investigators
have failed to demonstrate these activities in purified Nef
proteins, attributing the original finding to bacterial contam-
ination (27; reviewed in reference 28). Our sequence analysis
confirms the lack of significant sequence similarity between
the Nef protein sequences and G proteins. The proposed G
site (positions 183 to 186) was relatively conserved among
our Nef sequences, but it overlapped the LTR and did not
correspond to a Nef-defining sequence. Although the C site
overlapped a Nef-defining sequence (block B), the site was
only partially conserved among our sequences (positions 108
to 111). Furthermore, the proposed P site (positions 94 to 99)
aligned only if the chemical polarity of the amino acid
sequence was inverted. Taken together, the sequence and
biochemical analyses indicate that Nef fails to exhibit fea-
tures suggestive of G proteins.
Searches for cellular or viral proteins that contain Nef-
defining sequences. We used the most highly conserved
regions in the Nef sequence to conduct data base searches
for known protein sequences sharing significant similarity
with Nef, using various GCG (16) and Staden (59) search
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Search pattern--Block A 62d.e-VGfPV-P-VPLR-mtYKaAvDlSHFL: I1:
human: Rosl IS7 LIISWRE0SHPNGPKESVRYQLAISHL0LI
Search pattern--Block A *2de.-VGfPV-P-VPLR-mtYKaAvDlSHFL
yeast: RAP1 isiVPLLICRVYYCKIXFSXFDYHCSLCYLRFC
Search pattern--Block A 62d.-VGfPV-P-VPLR-mtYKaAvDlSHFL
1:: :: 1:: 11 11
D. sylhrilij: tet :AFTDVSPGXXSLIFFRO4AFPLYS.LS.FL
FIG. 5. Results of the protein sequence library searches for
known proteins that share sequence similarity with the four Nef-
defining sequences. (A) Example of results from a search of the PIR
protein sequence library using the block A Nef-defining sequence.
The PIR protein sequence data base library was searched by the
Analysepl program (59) with the block A Nef-defining sequence
E/D-E/D/N-E/D-E/L-V-G-V/F/I-P/S-V-X-R/P-Q/R/K-V-P/S-LJT-R-
X-X-T/S-Y-R/K-X-A/L-X-D-X-S-H-F-L/I (abbreviated as dee-
VGfPV-VPLR-mt-TKaAvDISHFL; invariant residues [upper case],
highly conserved residues [lower case], poorly conserved residues
[-]). The scores of the alignments (x axis) are plotted as a function of
the number of matches having that score (in parentheses, y axis).
Nef matches are depicted with solid bars; non-Nef matches are
shown with open bars. (B) Alignments of the block A query
sequence and the best non-Nef matches. The block A sequence
(abbreviated as described in panel A) was aligned to the best
non-Nef matches by the TFastA program of GCG (16). The best
non-Nef matches were the human transmembrane tyrosine-specific
kinase (ROS1) protein (two alleles, accession numbers M34353 and
X51619), the Saccharomyces cerevisiae DNA-binding protein RAP1
(accession number P11938), and the Bacillus subtilis tetracycline
resistance determinant (accession number X08034). Sequence sim-
ilarity with block A is noted as follows: identical residues ( )
highly conserved residues (:).
utilizing the Nef-defining domains (blocks A through D)
individually in an initial screen. This approach readily iden-
tified all the varied Nef sequences in the data base as a
distinct subset of sequences (see Fig. 5A for an example). As
expected, an increasing number of matches was found with
lesser match scores. The heterologous proteins with the
highest scores have very different biochemical activities and
align over different regions of the query sequence (Fig. SB),
indicating that most, if not all, of these alignments represent
background. In an effort to avoid fortuitous alignments, we
evaluated the matches having the best scores using the
following criteria: (i) identify the best alignments from
searches using each of the blocks individually; (ii) use this
subset of sequences to find the best alignments with the
other blocks; (iii) evaluate the linear order of the aligned
blocks compared to the order of the blocks in Nef; and (iv)
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FIG. 6. Stable expression of the HIV-1 nef consensus gene
transduced into HeLa cells. (A) Nef amino acid sequence predicted
from the HIV-1 nef consensus gene. A gene encoding the HIV-1
consensus Nef sequence was synthesized through a combination of
overlapping-primer PCR amplification and site-directed mutagene-
sis. The amino acid sequence of this gene corresponds exactly to the
Nef consensus sequence depicted in Fig. 1 except that the proline
within the region of variable duplication was omitted (see text). The
locations of the myristylation signal, sequence polymorphism,
highly charged/acidic region, [Pxx]4 repeat, putative PKC phosphor-
ylation site (PKC), PPT, 5' border of the 3' LTR ( -k), and the
predicted beta-turn are indicated above the sequence. Position
numbering is indicated above the Nef sequence. (B) Retroviral
vectors pLConsNefSN and pLConsFenSN. The HIV-1 consensus
nef gene was cloned into the pLXSN retroviral vector at the
EcoRI site in the forward (pLConsNefSN, consNef) and reverse
(pLConsFenSN, consFen) orientations. The consensus nef gene is
expressed from the Moloney murine leukemia virus LTR. Other
abbreviations: SV, simian virus 40 early promoter; neo, neor gene;
pA, polyadenylation site. (C) Immunoblot analysis of HeLa cells
expressing the HIV-1 consensus Nef protein. PA317 cells were
transiently transfected with the pLConsNefSN and pLConsFenSN
retroviral DNAs. Virus was harvested and used to infect HeLa cells.
G418-resistant cells were selected and analyzed via immunoblotting
for expression of the HIV-1 consensus Nef protein. Cellular lysates
assess the level of conservation of polar and charged amino
acids that are invariant in Nef sequences. We reasoned that
polar and charged residues are more likely to be involved in
catalytic function, as opposed to hydrophobic residues that
are more likely to have a structural role and thus may be less
conserved. Using this approach, we were unable to identify
satisfactory alignments between Nef and any heterologous
protein in the available data bases. Searches for known
structural and sequence motifs by the GCG ProfileScan and
Motifs programs, respectively, also failed to identify known
motifs within either the consensus Nef sequence or the 54
individual Nef sequences (data not shown).
The consensus nef gene expresses a full-length, stable Nef
protein within infected HeLa cells. A gene encoding the
consensus Nef amino acid sequence was constructed, using
a combination of PCR amplification and site-directed muta-
genesis. The sequence of the consensus nefgene is shown in
Fig. 6A. This sequence corresponded exactly to the Nef
consensus sequence depicted in Fig. 1, except that the
proline at position 23 within the variable duplication region
was omitted. This choice was made based on the observation
that proline was present only as part of the irregular series of
duplications that appeared in this region, and proline never
appeared alone in this position.
We used retrovirus-mediated gene transfer to establish
HeLa cells that stably expressed the consensus nef gene.
The retroviral vectors used in this study are diagrammed in
Fig. 6B. Immunoblot analysis of pooled G418-resistant in-
fected HeLa cells demonstrated that a Nef protein of ap-
proximately 27 kDa was expressed in the cells infected with
the pLConsNefSN vector, whereas no Nef protein was
detected in cells infected with the control pLConsFenSN
vector (Fig. 6C). In an initial examination of protein stabil-
ity, the half-life of the consensus Nef protein was estimated
at greater than 4 h as assessed by pulse-chase radiolabeling
experiments (data not shown), comparable to what has been
reported in the literature (28). Also, expression of the
consensus nef gene in cells expressing CD4 resulted in
suppression of cell surface CD4 expression (3), as has been
reported previously for nef alleles obtained from laboratory
HIV-1 strains (21, 21a, 24, 61).
The construction and expression of a nef gene encoding
the consensus Nef sequence represents a logical approach to
identify a functional nef gene. The lack of an assay for Nef
activity in the context of virus replication makes it difficult to
assess the competence of any specific nef allele. The con-
sensus nef gene should encode an optimally functioning
protein with which to explore the biological and biochemical
properties of Nef.
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